Sequential IPV-OPV polio vaccination schedule recommended by CDC cmte.; may go into effect by Jan. 1997.
Executive Summary
IPV-OPV POLIO VACCINATION SEQUENTIAL SCHEDULE MAY GO INTO EFFECT as early as January 1997, following the Centers for Disease Control & Prevention Advisory Committee on Immunization Practices' Oct. 18 recommendation to move away from the current oral polio vaccine-only approach. The 10-member panel, chaired by Jeffrey Davis, MD, Wisconsin Department of Health, unanimously agreed to a sequential childhood schedule of two doses of inactivated oral polio vaccine followed by two doses of OPV. CDC's acceptance of the recommendation will be published in an upcoming Morbidity and Mortality Weekly Report.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth